Calumet Inc (NASDAQ:CLMT)’s traded shares stood at 1.89 million during the last session, with the company’s beta value hitting 1.93. At the close of trading, the stock’s price was $18.93, to imply a decrease of -0.16% or -$0.03 in intraday trading. The CLMT share’s 52-week high remains $25.29, putting it -33.6% down since that peak but still an impressive 47.33% since price per share fell to its 52-week low of $9.97. The company has a valuation of $1.63B, with an average of 1.16 million shares in intraday trading volume over the past 10 days and average of 836.68K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Calumet Inc (CLMT), translating to a mean rating of 1.67. Of 2 analyst(s) looking at the stock, 0 analyst(s) give CLMT a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.54.
Calumet Inc (NASDAQ:CLMT) trade information
After registering a -0.16% downside in the last session, Calumet Inc (CLMT) has traded red over the past five days. The 5-day price performance for the stock is -11.17%, and -13.28% over 30 days. With these gigs, the year-to-date price performance is -14.03%. Short interest in Calumet Inc (NASDAQ:CLMT) saw shorts transact 6.03 million shares and set a 8.31 days time to cover.
The extremes give us $15.7 and $29 for target low and target high price respectively. As such, CLMT has been trading -53.2% off suggested target high and 17.06% from its likely low.
Calumet Inc (CLMT) estimates and forecasts
Looking at statistics comparing Calumet Inc share performance against respective industry, we note that the company has underperformed competitors. Calumet Inc (CLMT) shares are 18.16% up over the last 6 months, with its year-to-date growth rate lower than industry average at -657.63% against -5.80%. The rating firms project that company’s revenue will shrink -0.46% compared to the previous financial year.
Revenue forecast for the current quarter as set by 4 analysts is 921.76M. Meanwhile, for the current quarter, a total of 4 analyst(s) estimate revenue growth to 1.05B.Earnings reports from the last fiscal year show that sales brought in 976.5M and 1.01B respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -5.61% before jumping 4.35% in the following quarter.
CLMT Dividends
Calumet Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. The company’s average dividend yield trailing the past 5-year period is 14.83%.
Calumet Inc (NASDAQ:CLMT)’s Major holders
Calumet Inc insiders hold 21.20% of total outstanding shares, with institutional holders owning 37.64% of the shares at 47.77% float percentage. In total, 37.64% institutions holds shares in the company, led by WASSERSTEIN DEBT OPPORTUNITIES MANAGEMENT, L.P.. As of 2024-06-30, the company held over 6.89 million shares (or 8.5547% of shares), all amounting to roughly $110.61 million.
The next major institution holding the largest number of shares is ADAMS ASSET ADVISORS, LLC with 5.25 million shares, or about 6.5187% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $84.28 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Calumet Inc (CLMT) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 2.74 shares. This is just over 3.19% of the total shares, with a market valuation of $51.93 million. Data from the same date shows that the other fund manager holds a little less at 1.02, or 1.19% of the shares, all valued at about 19.38 million.
